FDA approves Alnylam’s anti-amyloid RNAi drug for cardiomyopathy

Nature Biotechnology, Published online: 14 April 2src25; doi:1src.1src38/s41587-src25-src2656-2FDA approves Alnylam’s anti-amyloid RNAi drug for cardiomyopathy…

Nature Biotechnology, Published online: 14 April 2src25; doi:1src.1src38/s41587-src25-src2656-2FDA approves Alnylam’s anti-amyloid RNAi drug for cardiomyopathy…
Read More

About Author

Lloyd Mcnaught

See author's posts

FDA approves Alnylam’s anti-amyloid RNAi drug for cardiomyopathy

About Author

Lloyd Mcnaught

I Tested Super Shoes Just Like Sports Scientists to See What Makes Them Work

‘Zombie’ skin cells may be harmful or helpful, depending on their shapes

What to know about processed and ultra-processed food

I Tested Super Shoes Just Like Sports Scientists to See What Makes Them Work

‘Zombie’ skin cells may be harmful or helpful, depending on their shapes

What to know about processed and ultra-processed food

Medical debt tied to higher likelihood of forgone mental health care

Survey reveals women may be experiencing perimenopause in their 40s

FDA outbreak investigations continue

Are Primary Care Visits Declining in the United States?

Rare ESWL Outcome: Liver Capsule Rupture Leads to Emergency

Do Ammonia Salts Pose a Health Risk for Hockey Players?

Extra Caution Needed for GLP-1s in Those With Chronic Issues

I Tested Super Shoes Just Like Sports Scientists to See What Makes Them Work

‘Zombie’ skin cells may be harmful or helpful, depending on their shapes

What to know about processed and ultra-processed food

Medical debt tied to higher likelihood of forgone mental health care

Survey reveals women may be experiencing perimenopause in their 40s

About PhaMed

Recent News

About Author

More Stories

You may have missed

About PhaMed

Recent News

Categories